SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Saint S, Lipsky BA. Preventing catheter-related bacteriuria. Should we? Can we? How? Arch Intern Med 1999; 159: 8008
  • 2
    Patel HRH, Arya M. The urinary catheter: ‘a-voiding catastrophe’. Hosp Med 2000; 62: 1489
  • 3
    Godfrey H, Evens A. Catheterization and urinary tract infections: microbiology. Br J Nursing 2000; 9: 68290
  • 4
    Haley RW, Hooton TM, Culver DH et al. Nosocomial infections in US hospitals 1975–76: estimated frequency by selected characteristics of patients. Am J Med 1981; 70: 94759
  • 5
    Platt R, Polk BF, Murdock B, Rosner B. Mortality associated with nosocomial urinary-tract infection. N Engl J Med 1982; 307: 63742
  • 6
    Krieger JN, Kaiser DL, Wenzel RP. Urinary tract etiology of blood stream infections in hospitalised patients. J Infect Dis 1983; 148: 5762
  • 7
    Bryan CS, Reynolds KL. Hospital-acquired bacteremic urinary tract infection: epidemiology and outcome. J Urol 1984; 132: 4948
  • 8
    Warren JW. Catheter-associated urinary tract infections. Infect. Dis Clin North Am 1997; 11: 60922
  • 9
    Kunin CM. Care of the urinary catheter in urinary tract infections. In KuninCM ed. Urinary tract infections. Detection, Prevention, and Management. 5th edn. Baltimore: Williams & Wilkins 1997: 22779
  • 10
    Stamm WE. Catheter-associated urinary tract infections. epidemiology, pathogenesis and prevention. Am J Med 1991; 91 (Suppl. 3B): 65S71S
  • 11
    Warren JW, Anthony WC, Hoopes JM, Muncie HI. Cephalexin for susceptible bacteriuria in afebrile, long-term catheterised patients. JAMA 1982; 248: 4548
  • 12
    Harding GKM, Nicolle LE, Ronald AR et al. How long should catheter-acquired urinary tract infection in women be treated? A randomised controlled study. Ann Intern Med 1991; 114: 7139
  • 13
    Davies AJ, Shroff KJ. When should a urine specimen be examined after removal of a urinary catheter? J Hosp Infect 1983; 4: 17780
  • 14
    Hamilton- Miller JMT. Pathogens other than Escherichia coli as aetiological agents in urinary tract infection. In BrumfittW, Hamilton-MillerJMT eds, Urinary tract infections. London: Chapman & Hall Medical, 1998: 5974
  • 15
    Bonadio M, Meini M, Spitaleri P, Gigli C. Current microbiological and clinical aspects of urinary tract infections. Eur Urol 2001; 40: 43944
  • 16
    Zhang YL, Geng SN, Lai FC, Wang NP. Survey on drug resistance to ciprofloxacin in common pathogenic bacteria. Di Yi Jun Yi Da Xue Xue Bao 2002; 22: 3789
  • 17
    Osterlund A, Olsson-Liljequist B. Fluoroquinolone resistance of human pathogenic bacteria. Resistant E. coli now appearing in Sweden. Lakartidningen 1999; 96: 19656
  • 18
    Goettsch W, Van Pelt W, Nagelkerke N et al. Increasing resistance to fluoroquinolones in Escherichia coli from urinary tract infections in the Netherlands. J Antimicrob Chemother 2000; 46: 2238
  • 19
    Schaeffer AJ. The expanding role of fluoroquinolones. Am J Med 2002; 113 (Suppl. 1A): 45S54S
  • 20
    Nicolle LE. Urinary tract infection: traditional pharmacologic therapies. Am J Med 2002; 113 (Suppl. 1A): 35S 44S
  • 21
    Sedor J, Mulholland SG. Hospital-acquired urinary tract infections associated with the indwelling catheter. Urol Clin North Am 1999; 26: 8218